Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Re...
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
About this item
Full title
Author / Creator
Signoriello, Elisabetta , Lus, Giacomo , Saccà, Francesco , Puthenparampil, Marco , Coppola, Cinzia , Di Pietro, Andrea , Puoti, Gianfranco , Criscuolo, Maria Cristina , Foschi, Matteo , Miele, Giuseppina , Abbadessa, Gianmarco , Brescia Morra, Vincenzo , Gallo, Paolo , Bonavita, Simona , Sormani, Maria Pia and Signori, Alessio
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
alemtuzumab is a monoclonal anti-CD52 antibody acting on B and T cells in highly active multiple sclerosis (MS). We analyzed changes in lymphocyte subsets after alemtuzumab administration in relation to disease activity and autoimmune adverse events.
lymphocyte subset counts were assessed longitudinally using linear mixed models. Subset counts a...
Alternative Titles
Full title
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10002781
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10002781
Other Identifiers
ISSN
2077-0383
E-ISSN
2077-0383
DOI
10.3390/jcm12051768
